Engineering Saccharomyces cerevisiae for the utilization of pentose sugars is an important goal for the production of second-generation bioethanol and biochemicals. However, S. cerevisiae lacks specific pentose transporters and, in the presence of glucose, pentoses enter the cell inefficiently via endogenous hexose (HXT) transporters. By means of in vivo engineering, we have evolved a quadruple hexokinase deletion mutant of S. cerevisiae into a strain that efficiently utilizes D-xylose in the presence of high D-glucose concentrations. Genome sequence analysis revealed a mutation (Y353C) in the general co-repressor CYC8/SSN6, which was found to be responsible for the phenotype when introduced individually in the non-evolved strain. Transcriptome analysis revealed the altered expression of in total 95 genes, including genes involved in: 1) hexose transport, 2) maltose metabolism, 3) cell wall function (mannoprotein family), and 4) unknown functions (Seripauperin multigene family). Out of the 18 known HXT transporters, 9 were upregulated, especially the low or non-expressed HXT10, HXT13, HXT15 and HXT16 genes. Mutant cells show increased uptake rates of D-xylose in the presence of D-glucose, as well as an elevated Vmax for both D-glucose and D-xylose transport. The data suggests that the increased expression of multiple hexose transporters renders D-xylose metabolism less sensitive to D-glucose inhibition due an elevated transport rate of D-xylose into the cell.
BACKGROUND
Increasing energy demand and concerns of obtaining this energy from fossil fuels have stimulated the development of liquid fuels from renewable feedstock. Bioethanol, mostly used as a fuel additive, produced from readily fermentable agricultural feedstocks like sugar cane and corn is less desired because the production of these feedstocks requires large amounts of arable land while competing with food supply (1). A more sustainable source of feedstock is lignocellulosic biomass from hardwood, softwood and agricultural residues (2). However a major drawback of lignocellulosic feedstocks is the inability of the most commonly used yeast in industry, Saccharomyces cerevisiae, to ferment the substantial fraction of pentose sugars, such as D-xylose, released upon conversion of lignocellulose besides the hexose sugar fraction (4). In recent years, two strategies have been developed to equip S. cerevisiae with the ability to convert D-xylose into bioethanol: 1) the XR-XDH pathway, a two-step redox pathway in which xylose reductase (XR) first catalyzes the reduction of xylose to xylitol, which is subsequently oxidized via xylitol dehydrogenase (XDH) to form xylulose (7, 8) and 2) the XI pathway, a one-step conversion from xylose into xylulose using either a bacterial or fungal xylose isomerase (9-11). The latter pathway, overexpressing the fungal xylose isomerase of Piromyces sp. E2 is used in this study. To further optimize the flux of xylose fermentation towards ethanol the endogenous genes of the non-oxidative pentose phosphate pathway were over-expressed [8] .
Although overexpression of the xylose isomerase results in the desired D-xylose fermentation, the consumption of D-xylose in the presence of a high glucose concentration remains difficult (36). All currently used xylose-fermenting S. cerevisiae strains first consume the D-glucose, before D-xylose is metabolized. To generate an economically feasible process in an industrial setting, it is preferred that both sugars are fermented simultaneously and at high consumption rates (121). Pentose transport and the quest for co-consumption of D-xylose and D-glucose is an important topic in xylose fermenting strains. Various approaches have been used including the introduction of specific xylose transporters derived from other organisms (56, 122) , but these support only low rates of xylose transport (47, 48, 116, 123) . Another approach, reported recently, is the mutagenesis of the hexose BACKGROUND RESULTS transporters HXT7 and GAL2 genes yielding mutants that were found to be defective in glucose uptake while still retaining substantial xylose transport activity (65). In another study it was shown that, via saturated mutagenesis of conserved amino acid sequence motifs, HXT7 could be converted in a D-xylose transporter. However, this rewired transporter remained sensitive to glucose inhibition (33). The extensively studied hexose transporter (HXT) family of sugar transporters mediate glucose transport in S. cerevisiae (34, 35) . In a strain, lacking the main hexose transporters HXT1-7 and GAL2, uptake of D-xylose could be restored by the re-introduction of HXT1, HXT2, HXT4 and HXT7 (70) . In another study, HXT3 and a HXT36 chimera were shown to complement growth on D-xylose (72). Furthermore, in a D-xylose-fermenting S. cerevisiae strain in which all hexose transporters were deleted, it was shown that HXT5 also transports D-xylose [9] . However, all of these expressed HXT transporters have in common that the preferred substrate is D-glucose and not D-xylose. In the quest for a specific D-xylose transporter we recently showed that via a combinatorial approach of evolutionary engineering and directed evolution, the HXT36 gene, a chimeric HXT in which HXT3 and HXT6 are fused, could be converted in a specific D-xylose transporter by a single amino acid change allowing co-metabolism of D-glucose and D-xylose (72). The best mutant, however, showed a rather low Vmax on D-xylose, which limited the growth rate on this sugar. To further optimize D-xylose transport in the presence of D-glucose we have used an in vivo evolutionary engineering method using a xylose-fermenting S. cerevisiae strain that lacks the four hexokinase genes (65, 72) . This strain is therefore unable to grow on D-glucose, but still ferments D-xylose. By growing this strain on repeated batches of D-xylose in the presence of increasing concentrations of D-glucose, an evolved strain was obtained in which transport and metabolism of D-xylose is highly resistant to D-glucose. Genome sequencing and expression analysis indicates that the growth phenotype can be explained by a mutation in the CYC8/SSN6 gene, which leads to increased expression levels of the HXT transporters causing a higher transport flux of D-xylose into the cell in the presence of D-glucose.
RESULTS

EVOLUTIONARY ENGINEERING OF A S. CEREVISIAE QUADRUPLE HEXOKINASE DELETION STRAIN ON D-XYLOSE IN THE PRESENCE OF INCREASING D-GLUCOSE CONCENTRATION
The S. cerevisiae quadruple hexokinase (GLK1, HXK1, HXK2 and GAL1) deletion strain DS69473 (72, 77) was grown in a fermentor in order to select for an improved growth on D-xylose in the presence of D-glucose. This strain contains an engineered D-xylose metabolic pathway, based on a fungal xylose isomerase and is thus capable of growing on D-xylose (9-11) but it does not grow on D-glucose. The experiment was designed to isolate an evolved D-xylose-fermenting strain that is less sensitive to D-glucose inhibition. The DS69473 strain was grown aerobically in batch culture on 1 % D-xylose in the presence 3 % D-glucose and, in time, increasing concentrations of D-glucose up to 8 % (Supplemental Figure 1) . Growth was assayed via CO2 production and optical density measurements during the fermentation. Because of the experimental batch culture setup the strain consumes the D-xylose whereas the 
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D-glucose concentration remains unaltered. This leads, in time, to increasing D-glucose to D-xylose ratios and therefore decreased growth rates as observed in the CO2 measurements. If needed, D-xylose was added to maintain growth. To further challenge the strain, slowly the D-glucose concentration was increased in a 40-day time frame in which the wild-type DS69473 adapted to the increasing ratio of D-glucose to D-xylose. This led to the evolved DS69473Evo strain, which was able to grow on D-xylose (1 %) in the presence of a 8-fold excess of D-glucose (8 %). The DS69473Evo strain was analyzed for growth in shake flasks on 2 % D-xylose in the presence of various concentrations of D-glucose and compared to the progenitor DS69473. Both strains show comparable growth profiles on 2 % xylose without glucose. Growth of the original DS69473 strain and the evolved DS69473evo strain was inhibited at 6 % D-glucose although the DS69473Evo strain grows to higher OD600 levels compared to the parental strain ( Figure 1 ). Growth of the DS69473 strain on 2 % D-xylose in the presence of 12 % D-glucose is completely inhibited, while the DS69473Evo strain is still able to grow.
As expected, control experiments demonstrated that these strains are unable to consume and grow on D-glucose (data not shown).
D-XYLOSE UPTAKE IN THE PRESENCE OF D-GLUCOSE
To investigate the molecular basis that allows growth of the DS69473Evo strain on D-xylose in the presence of competing concentrations of D-glucose, [ 14 C-] D-xylose uptake experiments were carried out. Already with 100 mM (~1.5 %) xylose and without glucose in the buffer, the DS69473Evo strain showed an increased rate of D-xylose uptake (49.8 ± 3.7 nmol/mgDW.h) compared to the original DS69473 strain (32.2 ± 1.3 nmol/mgDW.h) (Figure 2 ). With both strains, D-xylose transport was inhibited by D-glucose but a substantial residual D-xylose uptake rate remained with the DS69473Evo strain at the highest D-glucose concentrations tested. If the uptake rates were compared relative to the D-xylose uptake in the absence of D-glucose, the difference between both stains was negligible (Figure 2, inset) . This suggests that the evolution experiment resulted in an increased D-xylose transport activity but that the D-glucose sensitivity remained unchanged.
GENOME SEQUENCING
Genome sequencing of DS69473 and DS69473Evo was conducted to find mutations that enabled the evolved strain to grow on 1 % Dxylose in the presence of 8 % D-glucose. Sequencing data was mapped to CEN.PK113-7D strain (124). Unique variants (insertion, deletion, multinucleotide (MNV) and single nucleotide polymorphisms (SNP)) were detected by comparing the DS69473 and DS69473Evo genomes. When selecting variants that are found only in DS69473Evo one interesting mutation was obtained in the CYC8/SSN6 gene (see Supplemental Table 1 for total variants of DS69473Evo). This point mutation (1058A>G) in CYC8/SSN6 resulted in an amino acid change Y353C and was found in 335 out of 336 reads that map at that position meaning a high coverage and frequency. The presence of the mutation was checked in predecessors' strains, but found to be absent in the lineage (data not shown). Since the glucose/xylose uptake was changed in the DS69473Evo strain we focused especially on all the HXT transporters 
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in the genome comparison between the DS69473Evo strain and the DS69473 yielded no differences. However, both strains showed a stop codon in HXT13 at position 842 (W281stop), which is also present in the CEN.PK113-7D strain (124). Furthermore, both strains have a synonymous substitution in the HXT10 gene (A1587G), which is not present in the genome of CEN.PK113-7D.
REVERSE ENGINEERING OF CYC8 IN THE ORIGINAL DS69473 STRAIN
To validate the significance of the Y353C mutation in the CYC8 gene, the same mutation was reverse-engineered in strain DS69473. A similar strain containing the kanMX marker but not the CYC8 mutation was constructed as a control (DS69473-Y353). The obtained strains were tested for aerobic growth on 2 % D-xylose and 12 % D-glucose in shake flasks ( Figure 3 ) analogous to the evolution experiment. A highly similar growth pattern was obtained in the DS69473-Y353C strain compared to the DS69473Evo strain ( Figure 1 ). In contrast, the DS69473-Y353 control strain is unable to grow on 2 % D-xylose and 12 % D-glucose, and shows normal growth at 2 % D-xylose only (data not shown). This demonstrates that the Y353C mutation in the CYC8 gene is the main element responsible for the obtained phenotype in the DS69473Evo strain.
SATURATION MUTAGENESIS OF RESIDUE 353 OF CYC8
To explore the sequence space of position Y353 in Cyc8, all further amino acid substitutions were individually introduced into the CYC8 gene using the CRISPR/Cas9 technology. The Cyc8-Y353 mutants were transformed to the original DS69473 hexokinase deletion strain and tested for growth on 2 % D-xylose and 12 % D-glucose. Improved growth (within 48 hrs) occurred with 10 additional mutants relative to wild-type Cyc8 (Supplemental Figure 2) . However, none of these mutants showed a significantly improved growth rate compared to the 
TRANSCRIPTOME ANALYSIS OF THE CYC8 MUTANT STRAIN
To further examine the transcriptional impact of the CYC8 Y353C mutation, RNAseq analysis was carried out with the DS69473-Y353C and DS69473-Y353 strains, grown for 29 hours on 2 % D-xylose in the presence of 6 % D-glucose. In the comparison, 93 genes were upregulated and 2 genes were down-regulated in strain DS69473-Y353C (Supplemental table 2 ). The up-and down regulated genes are distributed over almost all chromosomes and four main functional clusters of genes could be identified: 1) the down-regulation of two maltose permeases (MAL11 and MAL31) and 2 maltases (MAL12 and MAL32), 2) the up-regulation of members of the Seripauperin multigene family (10 PAU genes up-regulated) and 3) up-regulation of the cell wall mannoprotein family (8 genes up-regulated e.g. TIR1, FIT2). Most notably, there was the 4) up-regulation of members of the hexose transporter family including highly (HXT1, HXT2, HXT36, HXT5 and HXT7) and silent or low expressed genes (HXT10, HXT13, HXT15 and HXT16) ( Table 1) . Combining the absolute expression levels of all HXT transporters, the overall expression was nearly 2-fold higher in the DS69473-Y353C mutant compared to the DS69473-Y353 control strain (Table 1) . RNAseq data of all the HXT transporters was confirmed by qPCR (data not shown). Out of the 93 up-regulated genes, 34 are located in the 30 Kbp of the telomeric region of the various chromosomes which is consistent with data published before (125). Next, uptake experiments with [ 14 C-] D-xylose were performed in order to study the effect of the increased expression of HXT transporters in the DS69473-Y353C mutant strain. The collective kinetic parameters for D-xylose uptake were improved in the DS69473-Y353C strain compared to the DS69473-Y353 strain, showing an increased Vmax (287.7 ± 14.5 nmol/mgDW.h versus 244.1 ± 24.1 nmol/mgDW.h) and an improved apparent Km (368.5 ± 48.0 mM versus 486.8 ± 60.9 mM) ( Figure 4 ). Uptake of D-glucose also was increased with a Vmax of 147.5 ± 7.2 nmol/mgDW.h in the DS69473-Y353C mutant versus 99.3 ± 4.5 nmol/mgDW.h in the DS69473-Y353Y control strain, with apparent Km values of 48.2 ± 2.9 mM and 29.9 ± 2.3 mM, respectively. It should be stressed that the above kinetic parameters are an approximation as they reflect the overall transport activity of the yeast strains.
Summarizing, these data demonstrate that the evolved strain exhibits enhanced rates of D-glucose and D-xylose transport. HXT1-HXT7 and GAL2 were deleted, were for both sugars subtracted from the DS69473 and the DS69473 Y353C strains to correct background sugar uptake and cellular binding.
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CHARACTERIZATION OF A CYC8 DELETION STRAIN
To investigate if the Y353C mutation in the CYC8 gene is a functional change or inactivation of the protein, a CYC8 deletion strain was studied. Although various attempts were made with the HIS3 marker as well as the kanMX marker and also with different flanking regions, no inactivation mutant of the CYC8 gene could be obtained in the original DS69473 hexokinase deletion strain. When the same constructs were transformed to the DS68616 strain, a xylose-fermenting strain with intact hexokinase genes, the appropriate deletion was obtained in which the CYC8 gene was replaced with the kanMX resistance marker as confirmed by PCR (data not shown). Additionally, the CYC8 Y353C mutation was introduced into DS68616, yielding strain DS68616-CYC8-Y353C and the control DS68616-CYC8-Y353 both harboring the kanMX resistance marker. All three strains were grown on 2 % D-xylose and 6 % Dglucose to the mid-exponential growth phase and total RNA was isolated. Using qPCR, ADH1, FIT2 and HXT13 were found to be 0.3 (p=0.028), 8.7 (p=0.034) and 36.2 (p=0.000) times up-regulated in the DS69473-Y353C strain, respectively. The DS68616-CYC8-Y353C mutant strain showed similar results as compared to the DS69473-Y353C mutant strain (ADH1 = 0.25 ± 0.02, FIT2 = 2.9 ± 0.10 and HXT13 = 16.62 ± 1.06). Likewise, the DS68616Δcyc8 strain showed a similar up-regulation for the HXT13 gene (14.9 ± 1.5) and a down-regulation for the ADH1 gene (0.42 ± 0.08). In this strain, the FIT2 gene (0.10 ± 0.01) was downregulated. HXT10 and HXT15/16, both characteristic for the Hxt upregulated phenotype, are respectively 5.82 ± 0.64 and 13.36 ± 1.04 fold upregulated in the DS68616Δcyc8 strain (Supplemental Figure 3) . It is of interest to note that the silent and inactivated HXT13 gene was also up-regulated in the DS69473evo and DS69473-Y353C strains (data not shown), suggesting a common mechanism.
CHARACTERIZATION OF A XYLOSE FERMENTING INDUSTRIAL STRAIN EXPRESSING CYC8-Y353C
The impact of the Y353C mutation in CYC8 on D-xylose consumption was further studied in an industrial relevant strain that carries the four hexose kinases (GLK1, HXK1, HXK2 and GAL1) and thus is capable of glucose consumption. DS68616-CYC8-Y353, DS68616-CYC8-Y353C and DS68616-ΔCYC8 strains were inoculated at an OD600 of 10 and grown for 8 hours on 2 % D-glucose and 2 % D-xylose.
Since the DS68616-ΔCYC8 strain flocculates and showed a severely reduced growth rate (data not shown), it was not further analyzed. Strain DS68616-CYC8-Y353C showed a reduced growth rate on the glucose-xylose mixture as compared to the DS68616-CYC8-Y353 wild-type strain (Supplemental Figure 4C ), but the initial D-xylose consumption was higher in the DS68616-CYC8-Y353C mutant strain as compared to the DS68616-CYC8-Y353 wild-type strain (Supplemental Figure 4B ). In contrast, D-glucose consumption remains unaltered (Supplemental Figure 4A ). This shows that also in a glucose consuming strain, xylose consumption is stimulated by the CYC8-Y353C mutation.
OVEREXPRESSION OF THE UP-REGULATED SILENT HXT TRANSPORTER GENES
To examine the role of individual up-regulated HXT transporters in the phenotype of the DS69473Evo strain, the genes of several HXT transporters were all amplified from genomic DNA of the DS69473Evo strain, and cloned in the yeast expression vector pRS313-P7T7 [22] . It should be noted that we assume that the DS69473 and DS69473Evo strains displays a deletion of the last 18.9 Kbps of the telomeric region of the right arm of chromosome XIV, including HXT17 (YNR072W). This is partially in contrast with the de novo genome sequencing of the progenitor strain CEN.PK113-7D where only the genes YNR070W, YNR071C, YNR074C, YNR075C and YNR077C were found to be deleted which cover different parts of the telomeric region (124). However, the genes reported to be present in this study, YNR072W (HXT17), YNR073C (DSF1) and YNR076W (PAU6) all have a homolog elsewhere on the genome with 97, 99 and 100 % similarity, respectively. Therefore, it appears that these were mapped incorrectly and that instead the entire 18 Kbps DNA fragment was deleted in CEN.PK113-7D strain. PCR amplification on genomic DNA of the yeast strains S288C, CEN. PK113-7D and DS69473 showed that 3 out of 3 fragments failed to be amplified in the latter two strains whereas in the S288C strain, this amplification was possible (data not shown). Since HXT13 contains a stop DISCUSSION DISCUSSION codon in at position 842 (W281stop), it was not further examined for overexpression and complementation. Moreover, due to the very high nucleotide sequence homology (99 %) between HXT15 and HXT16, the individual genes could not be separated by sequencing. In the DS69473 strain, HXT10 and HXT15/16 are not expressed. These genes are, however, up-regulated in the DS69473Evo strain and were therefore also over-expressed individually in the hexose transporter deletion strain, in which HXT10 and HXT15/16 are silent (see Supplemental Table 3 ). Both HXT10 and HXT15 were able to complement growth on 2 % D-glucose (Supplemental Figure 5A) . However, only HXT10 showed growth complementation on 2 % D-xylose (Supplemental Figure 5B ), but growth was relatively poor compared to other HXT genes (e.g. HXT2 and HXT7; data not shown). Thus, HXT10 was not further analyzed. These data suggest that HXT transporters individually are not responsible for the observed phenotype. Rather, the CYC8 mutation causes an increased expression of a set of HXT transporters thereby changing the transporter landscape and concomitant elevated rates of D-glucose and D-xylose transport.
DISCUSSION
In the yeast Saccharomyces cerevisiae, HXT transporters (HXT1-HXT7) function as facilitators for D-glucose uptake allowing cells to grow efficiently on media containing high concentrations of this sugar. In an industrial setting, where a xylose-fermenting S. cerevisiae strain is used to convert D-xylose and D-glucose from lignocellulosic biomass into bioethanol, co-consumption of these sugars is essential to shorten fermentation times and to prevent inhibitory effects by toxic metabolites on D-xylose metabolism that is usually slower in these engineered strains. Co-metabolism is therefore desired for the development of a robust fermentation process. Although the S. cerevisiae strain DS68616 used in this study metabolizes D-xylose efficiently, the uptake, and therefore consumption, of D-xylose, is strongly inhibited by D-glucose. This is because D-xylose is transported via HXT transporters that prefer D-glucose above D-xylose (36, 70, 72) . To overcome this glucose transport inhibition and to select for mutants with an increased and more specific D-xylose uptake, a D-xylose-metabolizing DS69473 strain was used which lacks the four hexokinase genes and is thus unable to grow on D-xylose in the presence of high concentrations of D-glucose. This strain does not grow on D-glucose because of the inability to metabolize this sugar. The evolutionary engineering process yielded the DS69473Evo strain, which is able to grow on a high ratio of D-glucose to D-xylose. Uptake experiments indeed show an improved D-xylose uptake in the presence of increasing concentration of D-glucose, albeit D-xylose uptake remains to be inhibited. Genome sequencing of the evolved DS69473Evo strain identified the Y353C mutation in the CYC8 gene and by transcriptomics, the subsequent increased expression of a large number of the HXT transporters could be demonstrated causing both an increased Vmax of D-xylose and D-glucose uptake. Further mutagenesis of the Y353 position, showed that other substitutions can result in improved growth, but the original cysteine mutant appears to exhibit the strongest phenotype. A previous study also described a point mutation in the CYC8 gene in an evolutionary engineering experiment which optimized D-xylose consumption in a D-xylose fermenting S. cerevisiae strain (126). Either because of that mutation, or two other mutations found in the evolved strain (126), the expression levels of the genes involved in xylose metabolism (e.g. XYL1 and XYL2) were increased causing improved D-xylose consumption but not an increased growth on D-xylose in the presence of D-glucose. The Y353C mutation in the CYC8 gene is located in the before last (number 9 out of 10) tetratricopeptide (TPRs) which are functional domains required for the interaction with Tup1p. A distinct subset of TPR motifs is needed for the repression of different classes of genes affected by the Cyc8p-Tup1p co-repressor complex, especially TPRs 8 and 9, and possibly 10. These are shown to be critical for glucose repression (127, 128). During glucose repression, the Cyc8p-Tup1p co-repressor complex interacts with Mig1p and inhibits Mig1p activation (99, 129) . Transcriptome data of a S. cerevisiae wild-type strain in which the TUP1 gene was deleted showed the 2-fold upregulation of 225 genes including 15 genes encoding or involved in flocculation, serine-rich cell wall mannoproteins, seripauperin and the hexose transporter family (130). The latter group includes all HXT genes except for HXT5, HXT10 and HXT14. Although there is a major overlap in up-regulated HXT genes in our data set, the CYC8 mutation does not cause the upregulation of GAL2, HXT4, HXT8, HXT9, HXT11 and HXT14 and thus the phenotype differs from the tup1 deletion. Out of the 93 genes, which are up-regulated in the CYC8 DISCUSSION CONCLUSIONS Y353C mutant strain, 34 genes are 2-fold up-regulated in the tup1 deletion strain. Our data further demonstrates that a cyc8 deletion strain does not have the same phenotype as the CYC8 Y353C mutant strain. This CYC8 deletion strain showed a tendency to flocculate, which was not observed with the CYC8 Y353C mutant strain. Flocculation was also observed previously in a cyc8 (131) and tup1 (132, 133) deletion strain. However, since Hxk2p is a bi-functional enzyme, both a catalyst and an important regulator in glucose repression, the phenotype of a strain with 2 mutations in the glucose catabolite repression mechanism (CYC8 Y353C and Δhxk2) might differ from the one with only the CYC8 Y353C mutation. Overall we conclude that the phenotype of the Y353C mutation in the CYC8 gene has substantial overlap with phenotype of strains carrying a deletion of the CYC8 or TUP1 gene. It should also be noted that in addition to the aforementioned functional classes of genes including the HXT transporters, a number of individual genes were up-regulated. In particular, the almost 6-fold upregulation of TKL2 gene is of interest as this gene encodes for a transketolase that catalyzes the conversion of xylulose-5-phosphate and ribose-5-phosphate to sedoheptulose-7-phosphate and glyceraldehyde-3-phosphate in the pentose phosphate pathway and thus in the metabolism of D-xylose. The low expressed TKL2 is a paralog of TKL1. Although the TKL1 gene is 1.4-fold down-regulated in the CYC8 mutant strain, its expression is still 26-fold higher than TKL2. Based on the expression levels, it appears unlikely that an increased TKL2 expression causes a major change in D-xylose metabolism. The upregulated genes HXT15 and HXT16 have recently been identified as mannitol and sorbitol transporters (134). They, cluster with the sorbitol dehydrogenases SOR2 and SOR1 genes, respectively. The latter genes were also upregulated in the DS69473 Y353C mutant strain (Supplemental table 2 ). However, upregulation of SOR1 could also be caused by the increased influx of D-xylose into the cell since D-xylose induces the expression of SOR1 (135). This may also apply to SOR2. Furthermore, HXT15 is able to transport xylitol, which may have a negative effect on biomass and/or ethanol production since xylitol inhibits the xylose isomerase (17). It should be noted that in the DS69473 derived strains, the aldose reductase GRE3 was deleted to prevent accumulation of xylitol. Although the upregulation of silent hexose transporters HXT10 and HXT15 occurred in the CYC8 Y353C mutant, these HXTs do not substantially contribute to the overall phenotype of an increased growth rate on D-xylose in the presence of D-glucose. The genes are low expressed and individually, could not fully complement a transporter deletion strain for xylose transport and metabolism. We conclude that the phenotype relates to the increased expression of the "main" hexose transporters HXT2, HXT36, and HXT7 and to a lesser extent HXT5, and HXT1 causing elevated rates of uptake of both D-glucose and D-xylose. Under these conditions, D-glucose remains the most favorable transported sugar, but because of the higher transport capacity, also an increased rate of D-xylose transport is observed driving improved D-xylose metabolism. Thus, mutation of CYC8 might be a general means to increase the expression of HXT transporters in order to improve hexose/pentose co-metabolism.
CONCLUSIONS
A mutation (Y353C) in the general transcriptional co-repressor CYC8 causes the altered transcription of a large group of genes involved in sugar metabolism and cell wall biogenesis, including the upregulation of almost all HXT transporter genes. This leads to an increased uptake of D-xylose in the presence of D-glucose, providing a general means to increase the sugar transport flux in strains that co-metabolize D-glucose and D-xylose.
METHODS
MOLECULAR BIOLOGY TECHNIQUES AND CHEMICALS
DNA polymerase, restriction enzymes and T4 DNA ligase were acquired from Fermentas. Oligonucleotides used for strain constructions were purchased from Sigma-Aldrich (Zwijndrecht, the Netherlands). Yeast genomic DNA for genome sequencing was isolated using the YeaStar™ Genomic DNA Kit (ZymoResearch, Irvine, CA, USA) following manufacturer's instructions. Total RNA was isolated and cDNA was prepared from S. cerevisiae cells as described before (72). Antibiotics for selection of introduced constructs in yeast, hygromycin and geneticin (G418) were acquired from Invitrogen (Toulouse, France); nourseothricin was acquired from Werner Bioagents (Jena, Germany).
METHODS METHODS
STRAINS AND GROWTH CONDITIONS
The construction of DS68625 (71) Fed-batch cultures were grown in minimal medium supplemented with vitamin solution and trace elements (136) in a laboratory fermentor with a working-volume of 500 ml (Applikon, Schiedam, the Netherlands) at a temperature of 30 °C and pH 4.5. The dissolved oxygen (DO) was set at 5 %, stirring at 400 rpm and the starting OD600 was 0.2. Shake flask experiments at 200 rpm were also done in minimal medium supplemented with 2 % D-maltose, 2 % D-xylose/0.05 % D-maltose and 2 % D-glucose. The 0.05 % D-maltose was added in order to circumvent an elongated lag-phase in minimal medium with only 2 % D-xylose. Cell growth was monitored by optical density (OD) at 600 nm using an UV-visible spectrophotometer (Novaspec PLUS).
IN VIVO EVOLUTION
The quadruple hexokinase deletion mutant DS69473 was evolved in batch cultivation to grow on a 1 % D-xylose concentration in the presence of increasing concentrations of D-glucose (3-8 %). Growth of the DS69473 strain was followed in time by CO2 measurements, whereas the levels of D-xylose and D-glucose were monitored by HPLC analysis to confirm that the cells were growing solely on D-xylose. The D-glucose to D-xylose ratio at the start of the evolutionary engineering was kept low at a 1:3 ratio but increased during the experiment, eventually reaching 1 % D-xylose and 8 % D-glucose. In the setup used, the DS69473 strain consumes only the D-xylose, which leads to higher glucose to xylose ratios in time and therefore a drop in growth rate. When the CO2 production was reduced, additional xylose (5 ml of 50 % D-xylose added to 500 ml fermentor volume) was added to maintain growth. On average after 6-7 days the culture was diluted into fresh medium with a higher D-glucose to D-xylose ratio (Supplemental Figure 1) . After 40 days, the evolved DS69473 strain was plated on 1 % D-xylose and 8 % D-glucose. A single colony (DS69473Evo) was used for further analysis.
ANALYTICAL METHODS
HPLC (High performance liquid chromatography) (Shimadzu, Kyoto, Japan) was performed using an Aminex HPX-87H column at 65 °C (Bio-RAD) and a refractive index detector (Shimadzu, Kyoto, Japan) was used to measure the concentrations of D-glucose and D-xylose. The mobile phase was 0.005 N H2SO4 at a flow rate of 0.55 ml/min.
GENOME SEQUENCING
Both strains DS69473 and DS69473Evo were sequenced using Illumina HiSeq with mate-pair (50 bp long reads, insert size 3.2-6.3 kbp) and paired-end libraries (100 bp long reads, insert size 200-400 bp) at Baseclear B.V. (Leiden). For DS69473 31 million read pairs were obtained and for DS69473Evo 37 million read pairs. Data was of high quality (average Phred score >35). CLC genomics workbench 7.5.1 (Qiagen) was used to analyse the data. Reads were trimmed at Phred score of 30 and allowing only 2 ambiguous nucleotides per read. Both datasets retained more than 95 % of the data after trimming. Mapping was done versus CEN.PK113-7D public genome (124) downloaded as genbank file from NCBI (PRJNA52955; 70 scaffolds, 12 Mbp assembly) using strict alignment settings. This resulted in 78 % (DS69473) and 75 % (DS69473Evo) of the data mapped amounting to 300x coverage of the CEN.PK113-7D genome. The public CEN.PK113-7D genome assembly does not contain mitochondrial DNA, which explains the relative low mapping frequency. The low frequency variant detection from CLC genomics workbench was used to detect variants using a minimum count of 10 (at least 10 reads need to support the variant). Since these are haploid strains the variant frequency (number of reads supporting variant/total coverage at that position) was set to 80 %. 
SATURATION MUTAGENESIS OF CYC8 Y353
The Cas9 expression vector p414 TEF1p-Cas9-CYCt (Addgene) was cut using the restriction enzymes AdeI and MunI to remove the auxotrophic tryptophan marker. The KanMX marker was amplified (primers Supplemental Table 4 ) from gDNA template from the DS68625 strain and cut with the same restriction enzymes and subsequently ligated into plasmid p414 TEF1p-Cas9-CYCt yielding plasmid p414-KanMXTEF1p-Cas9-CYCt. The p414-KanMX-TEF1p-Cas9-CYCt plasmid was transformed to the DS69473 strain and the expression of the CAS9 gene was analyzed using qPCR. Herein, we used the Crispr/Cas9 protocol from Mans et.al. (137) and pMEL16 to express the guide RNA targeting the CYC8 gene at the Y353 position (Supplemental Figure  4) and targeting a PAM site 6 bp in front of the Y353 position. Two repair fragments with degenerated codons were used (Supplemental Table 4 ) in which the 353 position was replaced for a WNN or SNN yielding codons starting with a A/T or C/G, respectively. Transformation to the DS69473 strain yielded all amino acids at position 353 except for E, K, M, W and F that were obtained separately used specific repair fragments. All mutations were verified after sequencing of the CYC8 gene.
TRANSCRIPTOME ANALYSIS
Total RNA of both strains was isolated in triplicates after 29 hours of growth on 2 % D-xylose in the presence of 6 % D-glucose. RNAseq was analyzed on a Ion Proton™ Sequencer (PrimBio, USA) and high quality read data was obtained for both strains in triplicate with an average read length of 114 bp and an average number of reads of 11.2 M per sample. The FastQ files were run through a BowTie2-TopHat-SamTools pipeline and the resulting BAM files were analyzed in SeqMonk V0.27.0. The CEN.PK113-7D strain was used as a reference genome. All genes were quantified and run in an intensity difference statistical test in which a statistical difference of below 0.05 was used (p<0.05).
CYC8 GENE REPLACEMENT
In order to obtain the same Y353C mutation in the original DS69473 strain the CYC8 gene in the DS69473 strain was replaced with the mutant gene with a kanMX resistance marker in front of the CYC8 promotor region. A fragment of 52 base pairs was used as 5' flanking region and a major part of the CYC8-Y353C gene was used as 3' flanking region (Supplemental table 4 ). The kanMX resistance marker was amplified via PCR with the Phusion® High-Fidelity PCR Master Mix in HF buffer, using a forward primer (F kanMX 5'tail) with a 52 base pair deletion 5' flanking region (667-719 upstream of the CYC8 gene) and a reverse primer (R KanMX + CYC8) with a small 22 base pair amplification 3' flanking region (645-667 upstream of the CYC8 gene). The 3' flanking region was amplified using a forward primer (F kanMX + CYC8) which is the reverse compliment of the R kanMX + CYC8 primer and a reverse primer (R CYC8) which anneals 60 base pairs behind the Y353C mutation. Both fragments were used in an overlap PCR using only the outside primers (F kanMX 5'tail and R CYC8) in order to fuse the two fragments together. After transformation of the fused fragment into the DS69473 strain cells were plated on minimal medium containing 2 % D-xylose and G418 (200mg/l) . Colonies were tested via PCR using primers F CYC8 and R CYC8 (Supplemental table 4) and were subsequently sequenced. Sequences were verified for the presence or absence of the Y353C mutation in the CYC8 sequence.
CYC8 GENE DELETION
The kanMX resistance marker was amplified from genomic DNA of the DS68625 strain using the F 5'FR CYC8 kanMX and the R 3'FR CYC8 kanMX primers (Supplemental 
REAL-TIME PCR AND PRIMERS
Real-time PCR (qPCR) on the expression of the HXT1-17, GAL2 , ADH1, FIT1 and CAS9 genes was performed with the primers indicated in Supplemental Table 5 , using the SensiMix SYBR & Fluorescein kit (Quantace Ltd) and the iCYCLER iQ Real Time PCR instrument (BIO-RAD). In all experiments actin was used as reference gene to normalize fold changes. The SYBR green Master Mix was used as described before (72).
CLONING OF HXT10 AND HXT15 GENES
The genes HXT10 and HXT15 were amplified from genomic DNA of the DS69473Evo strain using the primers listed in Supplemental Table 4 with the Phusion® High-Fidelity PCR Master Mix with HF buffer. The full-length ORFs of HXT10 and HXT15 were amplified using primers F HXT10 XbaI, R HXT10 Cfr9I and F HXT15 XbaI and HXT15 Cfr9I respectively, and cloned into pRS313-P7T7. The vector pRS313-P7T7 was described before (72) and used for the expression of HXT transporters under control of the HXT7 promotor. The vector was derived from pRS313 (kindly supplied by DSM Biotechnology Center, The Netherlands) as backbone containing the histidine selection marker and the CEN/ARS low copy origin for cloning in yeast.
UPTAKE MEASUREMENTS
Uptake experiments were performed as follows: cells were grown for 24 hours at 30 °C in shake flasks in minimal medium containing 2 % D-xylose and were washed (via centrifugation at 3,000 rpm, 3 min, 20 °C) and re-suspended in minimal medium without carbon source. 
